Uric acid
Small molecule in Homo sapiens that 3 drugs act on.
- Drugs that act on it: 3
- Approved: 2
- In phases 1 to 3: 1
- Sponsors: 3
Who is on it, and how far along
Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Protein or peptide 3
| RasburicaseBoxed warning | Approved | Sanofi | Protein or peptide | Oxidative enzyme | 3 |
| PegloticaseBoxed warning | Approved | Amgen | Protein or peptide | Oxidative enzyme | 2 |
| Pegadricase | Phase 3 | Swedish Orphan Biovitrum | Protein or peptide | Oxidative enzyme | 0 |
| A Study of IN026 in Participants With Refractory Gout | Rasburicase | Phase 1 | Recruiting | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | May 14, 2026 |
| A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout | Pegloticase | Phase 3 | Recruiting | Amgen | Feb 5, 2026 |
| Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients | Pegloticase, Rasburicase | Phase 2 | Active, not recruiting | Arthrosi Therapeutics | Aug 12, 2025 |
| Mature B-Cell Lymphoma And Leukemia Study III | Rasburicase | Phase 2 / Phase 3 | Active, not recruiting | St. Jude Children's Research Hospital | Jan 12, 2010 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364183, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets